MELBOURNE: Melbourne patients will be the first in the world to access a breakthrough Alzheimer’s drug shown to wake people up from the devastating impacts of dementia.
Up to 300 Australians will be offered the chance to trial experimental drug Anavex 2-73 next year in a study hoped to be the biggest step since the 1990s in treating the disease.
The Phase II-III trial comes as results from an early stage trial revealed Anavex not only halted the progression of dementia, but even reversed its impact and restored functions.